<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2003-08-28">28/08/2003</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Joanne</forename><surname>Mccarthy</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephanie</forename><surname>Monaco</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2003-08-28">28/08/2003</date>
						</imprint>
					</monogr>
					<idno type="MD5">33BC78665A3C07C532A5E93436B27E7F</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T16:13+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>CDK5 is a Cyclin-dependent Ser/Thr kinase acting in the central nervous system (CNS). Its activity requires the interaction with a protein known as p35. Deregulation of CDK5 activity as a consequence of proteolytic processing of the p35 sununit to a p25 moiety containing the C-terminal portion of p35 has been reported. It is deemed that CDK5 deregulation is important for the development of neuro-degenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's disease. We have previously reported the crystal structure of the CDK5-p25 heterodimer <ref type="bibr" target="#b0">(Tarricone et al, 2001)</ref>. We are currently concentrating on the study of crystal structures of the heterodimeric enzyme with known and newly identified inhibitors of CDK5, to understand their mode of action, and to identify possible differences with other CDK-inhibitor interaction that may lead to the development of selective inhibitors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>We have determined the crystal structures of several CDK inhibitors bound to the active site of CDK5, using a trigonal crystal form with greatly improved properties relative to the initially identified monoclinic crystal form <ref type="bibr" target="#b0">(Tarricone et al 2001)</ref>. A manuscript describing the refined structures of three complexes of CDK5-p25 with small molecule inhibitors (Indirubin, Roscovitine, Aloisine) has been submitted for publication. We have also started a collaboration with the group of Ken Kosick (Harvard Medical School, Boston, USA) aimed at identifying non-active site inhibitors of this kinase, and at characterizing the crystal structures of the most promising leads. Dataset from a first batch of these inhibitors have been collected.</p></div>		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>from: 13/03/2003 to: 13/03/2003 from: 10/07/2003 to: 10/07/2003</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Structure and Regulation of the CDK5-p25nck5a Complex</title>
		<author>
			<persName><forename type="first">Cataldo</forename><surname>Tarricone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rani</forename><surname>Dhavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Junmin</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Liliana</forename><forename type="middle">B</forename><surname>Areces</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-Huei</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1097-2765(01)00343-4</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Cell</title>
		<title level="j" type="abbrev">Molecular Cell</title>
		<idno type="ISSN">1097-2765</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="657" to="669" />
			<date type="published" when="2001-09">2001</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Tarricone C, Dhavan R, Peng J, Areces L, Tsai L-H, and Musacchio A (2001) Structure and regulation of the CDK5-p25 complex, Molecular Cell 8, 657-669</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Crovace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Massimiliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.2210/pdb1ung/pdb</idno>
		<imprint>
			<date type="published" when="2004-11-10" />
			<publisher>Worldwide Protein Data Bank</publisher>
		</imprint>
	</monogr>
	<note>a=b=117.5, c=156.8 Resolution (Å) 35.0-2</note>
	<note type="raw_reference">Mapelli M, Tsai L-h, Meijer L, and Musacchio A. Crystal structures of the CDK5-p25 complex bound to classical and non-classical cyclin-dependent kinase inhibitors, submitted Short summary of collected data CDK5-p25 with Aloisine Space Group P3221 Unit cell (Å) a=b=117.5, c=156.8 Resolution (Å) 35.0-2.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
